These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 31448694)
1. Molecular investigation against the resistant mechanism of PncA mutated pyrazinamide resistance and insight into the role of pH environment for pyrazinamide activation. Srivastava G; Darokar MP; Sharma A J Biomol Struct Dyn; 2020 Jul; 38(11):3411-3431. PubMed ID: 31448694 [TBL] [Abstract][Full Text] [Related]
2. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001 [TBL] [Abstract][Full Text] [Related]
3. Drug resistance mechanism of PncA in Mycobacterium tuberculosis. Rajendran V; Sethumadhavan R J Biomol Struct Dyn; 2014; 32(2):209-21. PubMed ID: 23383724 [TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China. Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021 [TBL] [Abstract][Full Text] [Related]
8. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313 [TBL] [Abstract][Full Text] [Related]
9. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582 [TBL] [Abstract][Full Text] [Related]
10. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance. Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767 [TBL] [Abstract][Full Text] [Related]
11. Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance. Khan MT; Malik SI J Biomol Struct Dyn; 2020 Jul; 38(10):3003-3017. PubMed ID: 31357912 [TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene. Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140 [TBL] [Abstract][Full Text] [Related]
13. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects. Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296 [TBL] [Abstract][Full Text] [Related]
15. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N. Junaid M; Khan MT; Malik SI; Wei DQ J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017 [TBL] [Abstract][Full Text] [Related]
16. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989 [TBL] [Abstract][Full Text] [Related]
17. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362 [TBL] [Abstract][Full Text] [Related]
18. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z; Zhang Y Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [TBL] [Abstract][Full Text] [Related]